http://www.fpnotebook.com/

Yellow Fever VaccineAka: YF VAX

See Also
1. Yellow Fever
2. Prevention of Vector-borne Infection
Mechanism
1. Live attenuated virus vaccine
Indications: Travel to Yellow Fever endemic areas
1. Sub-Saharan Africa
2. Amazon basin of South America
Dose: Patient over age 9 months
1. Dose: 0.5 ml subcutaneous every 10 years
Contraindications
1. Immunocompromised Patient
  1. HIV Infection
  2. Immunosuppressive medications
2. Pregnancy (relative contraindication)
3. Infant under age 6 months
4. Hypersensitivity to egg products
Efficacy
1. Effective in 100% of patients for 10 years

Navigation Tree

Please see the Terms and Conditions. Please also see the privacy statement regarding advertising on this page. Although access to this page is not restricted, the information found here is intended for use by medical providers. Patients should address specific medical concerns with their physicians.

This page was written by Scott Moses, MD. This page was last revised on 4/26/2008 9:16:33 PM. This page was last published on 4/29/2008. Please send comments and questions to the editor. Contact information may be found on the page About the Family Practice Notebook. These pages are best viewed with Microsoft Internet Explorer 6.0.

Infectious Disease Book

Approach

Bacterial Infections

Viral Infection

Human Immunodeficiency Virus Chapter related topics

Obstetrics Chapter related topics

Travel Medicine Chapter related topics

http://www.fpnotebook.com/

Yellow Fever VaccineAka: YF VAX

Navigation Tree